Assessment of tumor necrosis factor-α, interleukin-17, and vitamin D3 levels on a group of gastrointestinal tumor patients in Babylon Provence, Iraq

Q4 Medicine Medical Journal of Babylon Pub Date : 2023-04-01 DOI:10.4103/mjbl.mjbl_94_23
Aliyaa S. K. AL-Shimmery, Marwan Al-Alwany, Zainab Chabuck, R. AL–Mammori, T. Mokif, Zena Mahdi, Hussein O. M. Al-Dahmoshi, Noor Al-Khafaji, Hayder Abdul-Amir Makki Al-Hindy, Suhad Abed, Hadi Abdulabbas
{"title":"Assessment of tumor necrosis factor-α, interleukin-17, and vitamin D3 levels on a group of gastrointestinal tumor patients in Babylon Provence, Iraq","authors":"Aliyaa S. K. AL-Shimmery, Marwan Al-Alwany, Zainab Chabuck, R. AL–Mammori, T. Mokif, Zena Mahdi, Hussein O. M. Al-Dahmoshi, Noor Al-Khafaji, Hayder Abdul-Amir Makki Al-Hindy, Suhad Abed, Hadi Abdulabbas","doi":"10.4103/mjbl.mjbl_94_23","DOIUrl":null,"url":null,"abstract":"Background: Gastrointestinal (GIT) tumors refer to collection of tumor including colorectal, gastric, liver, and pancreatic tumors and other. Objective: The current study aims to measure the serum level of tumor necrosis factor-α (TNF-α), interleukin-17 (IL-17), and vitamin D3 among GIT tumor patients comparing with irritable bowel disease (IBD) patients and healthy control. Materials and Methods: Serum samples were taken from 88 participants (42 from malignant GIT tumor, 29 from benign GIT tumor, 10 from IBD (as positive control), and 7 from health individual (as negative control)). All patients admitted in GIT center of Babylon in Merjan Medical city at April up to December 2020. The TNF-α, IL-17, and vitamin D3 level were measured by Enzyme-Linked Immunoassay (ELISA. Results: The result showed younger men are more prevalent with malignant GIT tumor with mean age (53.39 years) than benign GIT tumor as well as IBD. There is an significant increase in TNF-α (Least Significant Difference (LSD = 1.79) levels of malignant GIT tumor when compared with other groups (mean ± Standard Deviation (SD) = 23.7 ± 8.1, 20.4 ± 2.8, 18.9 ± 2.66, and 18.1 ± 2.78 pg/mL for malignant GIT, benign GIT, IBD, and healthy persons respectively). Results of IL-17 level also reveal a significant increase (LSD = 13.2) of malignant GIT tumor when compared with other groups (mean ± SD = 222.2 ± 73.5, 128.2 ± 35.5, 201.5 ± 39.4, and 164.2 ± 44.1 pg/mL for malignant GIT, benign GIT, IBD, and healthy persons, respectively). Inverse results were documented for vitamin D3 level, in which a significant decrease (LSD = 23.45) in the levels of malignant GIT tumor was observed when compared with other groups (mean ± SD = 204.2 ± 24.3, 306.1 ± 97.2, 453.2 ± 78.2, 368 ± 78.0 pg/mL for malignant GIT, benign GIT, IBD, and healthy persons, respectively). Conclusion: The current study concluded that early age men get affected with malignant GIT tumor in Iraqi population giving a hint to that the population at high risk to involved with such tumor as well as other tumor types with elevated level of TNF-α and IL-17 and decreased level of vitamin D3. More and more studies with large number of patients should be recommended to exclude the factors in which that may lead to such conditions.","PeriodicalId":18326,"journal":{"name":"Medical Journal of Babylon","volume":"20 1","pages":"362 - 367"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Babylon","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/mjbl.mjbl_94_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Gastrointestinal (GIT) tumors refer to collection of tumor including colorectal, gastric, liver, and pancreatic tumors and other. Objective: The current study aims to measure the serum level of tumor necrosis factor-α (TNF-α), interleukin-17 (IL-17), and vitamin D3 among GIT tumor patients comparing with irritable bowel disease (IBD) patients and healthy control. Materials and Methods: Serum samples were taken from 88 participants (42 from malignant GIT tumor, 29 from benign GIT tumor, 10 from IBD (as positive control), and 7 from health individual (as negative control)). All patients admitted in GIT center of Babylon in Merjan Medical city at April up to December 2020. The TNF-α, IL-17, and vitamin D3 level were measured by Enzyme-Linked Immunoassay (ELISA. Results: The result showed younger men are more prevalent with malignant GIT tumor with mean age (53.39 years) than benign GIT tumor as well as IBD. There is an significant increase in TNF-α (Least Significant Difference (LSD = 1.79) levels of malignant GIT tumor when compared with other groups (mean ± Standard Deviation (SD) = 23.7 ± 8.1, 20.4 ± 2.8, 18.9 ± 2.66, and 18.1 ± 2.78 pg/mL for malignant GIT, benign GIT, IBD, and healthy persons respectively). Results of IL-17 level also reveal a significant increase (LSD = 13.2) of malignant GIT tumor when compared with other groups (mean ± SD = 222.2 ± 73.5, 128.2 ± 35.5, 201.5 ± 39.4, and 164.2 ± 44.1 pg/mL for malignant GIT, benign GIT, IBD, and healthy persons, respectively). Inverse results were documented for vitamin D3 level, in which a significant decrease (LSD = 23.45) in the levels of malignant GIT tumor was observed when compared with other groups (mean ± SD = 204.2 ± 24.3, 306.1 ± 97.2, 453.2 ± 78.2, 368 ± 78.0 pg/mL for malignant GIT, benign GIT, IBD, and healthy persons, respectively). Conclusion: The current study concluded that early age men get affected with malignant GIT tumor in Iraqi population giving a hint to that the population at high risk to involved with such tumor as well as other tumor types with elevated level of TNF-α and IL-17 and decreased level of vitamin D3. More and more studies with large number of patients should be recommended to exclude the factors in which that may lead to such conditions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伊拉克巴比伦普罗旺斯一组胃肠道肿瘤患者肿瘤坏死因子-α、白细胞介素17和维生素D3水平的评估
背景:胃肠道肿瘤是指肿瘤的集合,包括结直肠癌、胃癌、肝癌、胰腺癌等。目的:本研究旨在测定GIT肿瘤患者与肠易激综合征(IBD)患者和健康对照组血清肿瘤坏死因子-α(TNF-α)、白细胞介素17(IL-17)和维生素D3的水平。材料和方法:88名参与者的血清样本(恶性GIT肿瘤42例,良性GIT肿瘤29例,IBD 10例(阳性对照),健康人7例(阴性对照))。2020年4月至12月,Merjan医疗城巴比伦GIT中心收治的所有患者。采用酶联免疫吸附法(ELISA)测定肿瘤坏死因子-α、白细胞介素17和维生素D3水平。结果:青年男性恶性GIT肿瘤的发病率(53.39岁)高于良性GIT肿瘤和IBD。与其他组相比,恶性GIT肿瘤的TNF-α水平显著增加(最小显著差异(LSD=1.79))(平均值±标准差(SD)=23.7 ± 8.1、20.4 ± 2.8、18.9 ± 2.66和18.1 ± 恶性GIT、良性GIT、IBD和健康人分别为2.78pg/mL)。IL-17水平的结果还显示,与其他组相比,恶性GIT肿瘤显著增加(LSD=13.2)(平均值±SD=222.2 ± 73.5128.2 ± 2019年5月35日 ± 39.4和164.2 ± 恶性GIT、良性GIT、IBD和健康人分别为44.1 pg/mL)。记录了维生素D3水平的相反结果,其中与其他组相比,恶性GIT肿瘤的水平显著降低(LSD=23.45)(平均值±SD=204.2 ± 24.3306.1 ± 97.2453.2 ± 78.2368 ± 恶性GIT、良性GIT、IBD和健康人分别为78.0pg/mL)。结论:目前的研究得出结论,伊拉克人群中的早期男性会受到恶性GIT肿瘤的影响,这表明该肿瘤以及其他肿瘤类型的高危人群的TNF-α和IL-17水平升高,维生素D3水平降低。应该建议对大量患者进行越来越多的研究,以排除可能导致这种情况的因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.90
自引率
0.00%
发文量
21
审稿时长
8 weeks
期刊最新文献
Congenital atresia of posterior nares: Diagnosis and treatment at Hilla, Iraq Association of interleukin-4 in patients with recurrent aphthous stomatitis Study the effects of empagliflozin on model of chronic depression and interleukin-6 in the brain of male rats Molecular investigation of quinolone-resistant genes among clinical Staphylococcus aureus isolates in Babylon hospitals Investigating the potential correlation between vitamin D with rheumatoid factor, anticyclic citrullinated peptides antibody, and interleukin-12 levels in rheumatoid arthritis women in Erbil, Iraq
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1